Karuna Therapeutics (KRTX) Revenue Growth

Price: $329.83
Market Cap: $12.60B
Avg Volume: 971.83K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.149
52W Range: $158.375-329.99
Website: Karuna Therapeutics

What is Karuna Therapeutics's Revenue Growth?

  • Karuna Therapeutics's annual revenue growth as of FY 2023 is -93.85%.
  • Karuna Therapeutics's quarterly revenue growth as of Q4 2023 is 0.00%.

What is Revenue Growth?

Revenue growth is the increase in a company's sales over a specific period. It's a crucial metric for evaluating a company's financial health and its ability to expand its market presence and generate higher sales.

Related Metrics

Other important metrics to assess Karuna Therapeutics's financial performance include:

  • Revenue - the total revenue generated by a company:
    • Annual: $654.00K
    • Quarterly: $0
  • Cost of Revenue - the total cost of producing the goods or services sold by a company:
    • Annual: $1.70M
    • Quarterly: $447.00K
  • Cost of Revenue Growth - the rate at which a company's cost of revenue is growing:
    • Annual Growth: 52.97%
    • Quarterly Growth: -2.40%
  • Gross Profit - the difference between revenue and the cost of revenue:
    • Annual: $-1.05M
    • Quarterly: $-447.00K
  • Gross Profit Growth - the rate at which a company's gross profit is growing:
    • Annual Growth: -110.99%
    • Quarterly Growth: 2.40%

These metrics provide insights into Karuna Therapeutics's financial health and its ability to generate revenue efficiently. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Revenue Growth

-93.85%

Quarterly Revenue Growth

0.00%

Historical Annual Revenue Growth
0.00%0.00%-18.77%-18.77%-37.54%-37.54%-56.31%-56.31%-75.08%-75.08%-93.85%-93.85%Revenue Growth (Annual)20182018201920192020202020212021202220222023202320242024
Historical Quarterly Revenue Growth
8000.00%8000.00%6000.00%6000.00%4000.00%4000.00%2000.00%2000.00%0.00%0.00%-2000.00%-2000.00%Revenue Growth (Quarterly)20222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Historical Annual Revenue
$45.00M$45.00M$36.00M$36.00M$27.00M$27.00M$18.00M$18.00M$9.00M$9.00M$0.00$0.00Revenue (Annual)20182018201920192020202020212021202220222023202320242024
Historical Quarterly Revenue
$45.00M$45.00M$36.00M$36.00M$27.00M$27.00M$18.00M$18.00M$9.00M$9.00M$0.00$0.00Revenue (Quarterly)201920192020202020212021202220222023202320242024
Historical Annual Cost of Revenue
$2.00M$2.00M$1.60M$1.60M$1.20M$1.20M$800.00K$800.00K$400.00K$400.00K$0.00$0.00Cost of Revenue (Annual)20182018201920192020202020212021202220222023202320242024
Historical Quarterly Cost of Revenue
$500.00K$500.00K$400.00K$400.00K$300.00K$300.00K$200.00K$200.00K$100.00K$100.00K$0.00$0.00Cost of Revenue (Quarterly)201920192020202020212021202220222023202320242024
Historical Annual Gross Profit
$45.00M$45.00M$36.00M$36.00M$27.00M$27.00M$18.00M$18.00M$9.00M$9.00M$0.00$0.00-$9.00M-$9.00MGross Profit (Annual)20182018201920192020202020212021202220222023202320242024
Historical Quarterly Gross Profit
$45.00M$45.00M$36.00M$36.00M$27.00M$27.00M$18.00M$18.00M$9.00M$9.00M$0.00$0.00-$9.00M-$9.00MGross Profit (Quarterly)201920192020202020212021202220222023202320242024

Karuna Therapeutics Historical Revenue Growth Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2023.

Year Revenue Revenue Growth Cost of Revenue Cost of Revenue Growth Gross Profit Gross Profit Growth
2023 $654.00K -93.85% $1.70M 52.97% $-1.05M -110.99%
2022 $10.64M -71.22% $1.11M 119.76% $9.53M -73.87%
2021 $36.96M 0.00% $506.00K 248.97% $36.46M 25243.45%
2020 $- 0.00% $145.00K 150.00% $-145.00K -150.00%
2019 $- 0.00% $58.00K 0.00% $-58.00K 0.00%
2018 $- 0.00% $- 0.00% $- 0.00%
2017 $- 0.00% $- 0.00% $- 0.00%

Related Metrics

Explore detailed financial metrics and analysis for KRTX.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio